....I went back to my records on director Lekkas' buying.
Excluding the 20m he was issued as start up (deemed cost of $140k), he has paid from his own pocket a total of $299,833.66 for 31.5m shares. Last purchase 25/05/11. Has not reported any sales. For the record, he was not given any 1c options either.
Hanging in there, initial assay results can't be far off.
to calm my nerves a little....
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)